Meeder Asset Management Inc Evelo Biosciences, Inc. Transaction History

Meeder Asset Management Inc

  • $1.58 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$6.07 - $12.0 $53,768 - $106,296
-8,858 Closed
0 $0
Q3 2021

Nov 08, 2021
BUY
$6.79 - $13.9 $27,173 - $55,627
4,002 Added 82.41%
8,858 $61,000
Q2 2021

Aug 09, 2021
BUY
$9.43 - $16.6 $21,349 - $37,582
2,264 Added 87.35%
4,856 $67,000
Q1 2021

Apr 28, 2021
BUY
$9.71 - $18.6 $25,168 - $48,211
2,592 New
2,592 $28,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email